AFT Pharmaceuticals Statistics

Total Valuation

AFT Pharmaceuticals has a market cap or net worth of NZD 306.21 million. The enterprise value is 328.89 million.

Market Cap	306.21M
Enterprise Value	328.89M

Important Dates

The next estimated earnings date is Thursday, February 20, 2025.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

AFT Pharmaceuticals has 104.87 million shares outstanding. The number of shares has increased by 56.43% in one year.

Current Share Class	n/a
Shares Outstanding	104.87M
Shares Change (YoY)	+56.43%
Shares Change (QoQ)	-8.10%
Owned by Insiders (%)	69.44%
Owned by Institutions (%)	7.81%
Float	29.16M

Valuation Ratios

The trailing PE ratio is 28.71 and the forward PE ratio is 20.18. AFT Pharmaceuticals's PEG ratio is 0.99.

PE Ratio	28.71
Forward PE	20.18
PS Ratio	1.68
PB Ratio	3.65
P/TBV Ratio	11.22
P/FCF Ratio	11.98
P/OCF Ratio	n/a
PEG Ratio	0.99

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.91, with an EV/FCF ratio of 12.87.

EV / Earnings	28.34
EV / Sales	1.66
EV / EBITDA	15.91
EV / EBIT	17.15
EV / FCF	12.87

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.40.

Current Ratio	2.72
Quick Ratio	1.21
Debt / Equity	0.40
Debt / EBITDA	1.63
Debt / FCF	1.32
Interest Coverage	5.94

Financial Efficiency

Return on equity (ROE) is 14.40% and return on invested capital (ROIC) is 10.33%.

Return on Equity (ROE)	14.40%
Return on Assets (ROA)	7.82%
Return on Capital (ROIC)	10.33%
Revenue Per Employee	1.80M
Profits Per Employee	105,518
Employee Count	110
Asset Turnover	1.29
Inventory Turnover	2.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.57%
50-Day Moving Average	2.76
200-Day Moving Average	3.03
Relative Strength Index (RSI)	59.52
Average Volume (20 Days)	21,068

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AFT Pharmaceuticals had revenue of NZD 198.51 million and earned 11.61 million in profits. Earnings per share was 0.10.

Revenue	198.51M
Gross Profit	88.54M
Operating Income	19.18M
Pretax Income	17.21M
Net Income	11.61M
EBITDA	19.82M
EBIT	19.18M
Earnings Per Share (EPS)	0.10

Full Income Statement

Balance Sheet

The company has 10.69 million in cash and 33.64 million in debt, giving a net cash position of -22.95 million or -0.22 per share.

Cash & Cash Equivalents	10.69M
Total Debt	33.64M
Net Cash	-22.95M
Net Cash Per Share	-0.22
Equity (Book Value)	83.53M
Book Value Per Share	0.80
Working Capital	54.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.75 million and capital expenditures -190,000, giving a free cash flow of 25.56 million.

Operating Cash Flow	25.75M
Capital Expenditures	-190,000
Free Cash Flow	25.56M
FCF Per Share	0.24

Full Cash Flow Statement

Margins

Gross margin is 44.60%, with operating and profit margins of 9.66% and 5.85%.

Gross Margin	44.60%
Operating Margin	9.66%
Pretax Margin	8.67%
Profit Margin	5.85%
EBITDA Margin	9.98%
EBIT Margin	9.66%
FCF Margin	12.87%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.55%.

Dividend Per Share	0.02
Dividend Yield	0.55%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	14.46%
Buyback Yield	-56.43%
Shareholder Yield	-55.89%
Earnings Yield	3.48%
FCF Yield	8.35%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AFT Pharmaceuticals has an Altman Z-Score of 5.44.

Altman Z-Score	5.44
Piotroski F-Score	n/a